Role of current and emerging antithrombotics in thrombosis and cancer.
about
Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin.Long-term prognosis in patients continuing taking antithrombotics after peptic ulcer bleeding.Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: potential for regulation of tumor growth.Left atrium mass in a patient with breast cancer: a case report.Expression of coagulation factors and their receptors in tumor tissue and coagulation factor upregulation in peripheral blood of patients with cerebral carcinoma metastases.
P2860
Role of current and emerging antithrombotics in thrombosis and cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Role of current and emerging antithrombotics in thrombosis and cancer.
@ast
Role of current and emerging antithrombotics in thrombosis and cancer.
@en
type
label
Role of current and emerging antithrombotics in thrombosis and cancer.
@ast
Role of current and emerging antithrombotics in thrombosis and cancer.
@en
prefLabel
Role of current and emerging antithrombotics in thrombosis and cancer.
@ast
Role of current and emerging antithrombotics in thrombosis and cancer.
@en
P1433
P1476
Role of current and emerging antithrombotics in thrombosis and cancer.
@en
P2093
Shaker A Mousa
P304
P356
10.1358/DOT.2006.42.5.973580
P577
2006-05-01T00:00:00Z